FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to sulfonamide compound of the where R1 means alkyl, alkenyl, alkynyl; A means optionally substituted heterocyclic group excepting for benzimidazolyl, indolyl, 4,7-dihydrobenzimidazolyl and 2,3-dihydrobenzoxazinyl; X means alkylene, oxa-group, oxa-(lower)-alkylene; R2 means optionally substituted aryl, substituted biphenyl, its salt and pharmaceutical composition comprising this compound. The proposed sulfonamide compound is effective in treatment of diseases since it is able to decrease blood glucose level, to inhibit activity of cGMP-PDE (phosphodiesterase) and especially activity of PDE-V, to exhibit relaxing effect with respect to smooth muscles. Also, it exhibits bronchodilating activity, vasodilating activity, activity associated with suppression of smooth muscle cells and antiallergic activity. EFFECT: valuable medicinal properties of compound. 8 cl, 1 tbl, 399 ex
Title | Year | Author | Number |
---|---|---|---|
HETEROCYCLIC COMPOUND, METHOD FOR ITS PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2221792C2 |
AMIDES OF ACIDS, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2208608C2 |
BENZODIAZEPINE COMPOUND AND PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2496775C2 |
HETEROBICYCLIC DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2170737C2 |
1,2,3,4-TETRAHYDROPYRAZOLO-[5,1-C]-(1,2,4)-TRIAZINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION INHIBITING PRODUCING AN INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR, METHOD OF PROPHYLACTIC OR THERAPEUTIC TREATMENT OF PATIENTS WITH DISEASES MEDIATED BY INTERLEUKIN AND TUMOR NECROSIS FACTOR | 1994 |
|
RU2124517C1 |
MEDICINAL COMPOSITIONS | 1997 |
|
RU2197226C2 |
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
DERIVATIVES OF IMIDAZOLE, PHARMACEUTICAL COMPOSITION AND METHOD FOR PROPHYLAXIS AND/OR TREATMENT BASED ON THEREOF | 1999 |
|
RU2238937C2 |
6,7-UNSATURATED 7-CARBAMOYL SUBSTITUTED MORPHINANDERIVATIVE | 2006 |
|
RU2403255C2 |
AMINE DERIVATIVE POSSESSING ANTAGONISTIC ACTIVITY WITH RESPECT TO RECEPTOR NPY Y5 | 2007 |
|
RU2433119C2 |
Authors
Dates
2003-02-27—Published
1998-06-24—Filed